Back

Three-year follow-up of atrial fibrillation burden reduction after cryoballoon pulmonary vein isolation in early persistent atrial fibrillation: results from the COOL-PER trial

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Outcome of atrial fibrillation cryoablation Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Seokmoon Han

Seoul National University Hospital, Seoul (Korea (Republic of))

4 More presentations in this session

Presentation thumbnail
Comparative procedural outcomes of pulsed field, cryoballoon, and radiofrequency ablation for paroxysmal atrial fibrillation: a 15-year single-centre experience
Doctor N. Atan (Kuala Lumpur, MY)
Abstract Slides Video
Presentation thumbnail
Single-shot ablation for AF: real-world procedural and one-year outcomes with the newly adopted PulseSelect PFA compared with cryoballoon from the 1STOP project
Professor G. Boriani (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Timing of early recurrence predicts long-term outcomes after cryoballoon pulmonary vein isolation
Associate Professor A. Baimbetov (Almaty, KZ)
Abstract Slides Video
Presentation thumbnail
Very high-power short-duration ablation vs. cryoballoon for paroxysmal atrial fibrillation: a prospective single-center study with one-year follow- up
Doctor D. Debreceni (Pecs, HU)
Abstract Slides Video

Access the full session

Session thumbnail
Outcome of atrial fibrillation cryoablation

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Session
Late-Breaking Science: paroxysmal atrial fibrillation ablation
thumbnail
Congress Presentation
First-pass isolation as an independent predictor of atrial fibrillation recurrence after cryoballoon ablation in patients with persistent atrial fibrillation
thumbnail
Congress Presentation
A multicenter, prospective, randomized trial of treatment for early persAF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources